Solution-phase synthesis of pyrrole-imidazole polyamides

Journal of the American Chemical Society

Volumn 131, Issue 20, 2009, Pages 7175-7181

  Chenoweth, David M ^a   Harki, Daniel A ^a   Dervan, Peter B ^a  

^a California Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTORS; BIOPHYSICAL CHARACTERIZATION; BUILDING BLOCKES; CONVERGENT SOLUTIONS; DNA-BINDING; GRAM QUANTITIES; GRAM-SCALE QUANTITY; HAIRPIN POLYAMIDES; IN-CELL; PROSTATE CANCERS; PYRROLE-IMIDAZOLE POLYAMIDES; SOLID-PHASE METHOD; SOLID-PHASE METHODOLOGIES; SOLUTION PHASE SYNTHESIS;

AMIDES; AMINO ACIDS; ANIMAL CELL CULTURE; ANIMALS; CELL CULTURE; CELL MEMBRANES; CHROMATOGRAPHIC ANALYSIS; DNA; GENES; NUCLEIC ACIDS; OLIGOMERS; POLYAMIDES; SYNTHESIS (CHEMICAL);

DNA SEQUENCES;

IMIDAZOLE; POLYAMIDE; PYRROLE; IMIDAZOLE DERIVATIVE; NYLON; PYRROLE DERIVATIVE;

ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DNA BINDING; DNA SEQUENCE; PROSTATE CANCER; SOLID PHASE SYNTHESIS; CHEMISTRY; CONFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLUTION AND SOLUBILITY; SYNTHESIS; ULTRAVIOLET SPECTROPHOTOMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; NYLONS; PYRROLES; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 70149083228     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja901307m     Document Type: Article

References (42)

1. Dervan, P. B. Bioorg. Med. Chem. 2001, 9, 2215-2235.
2. Dervan, P. B.; Edelson, B. S. Curr. Opin. Struct. Biol. 2003, 73, 284-299.
3. (a) Trauger, J. W.; Baird, E. E.; Dervan, P. B. Nature 1996, 382, 559-561.
4. (b) White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B. Nature 1998, 397, 468-1170
5. (c) Kielkopf, C. L.; Baird, E. E.; Dervan, P. B.; Rees, D. C. Nat. Struct. Biol. 1998, 5, 104-109.
6. (d) Kielkopf, C. L.; White, S.; Szewczyk, J. W.; Turner, J. M.; Baird, E. E.; Dervan, P. B.; Rees, D. C. Science 1998, 282, 111-115.
7. Hsu, C. F.; Phillips, J. W.; Trauger, J. W.; Farkas, M. E.; Belitsky, J. M.; Heckel, A.; Olenyuk, B. Z.; Puckett, J. W.; Wang, C. C. C.; Dervan, P. B. Tetrahedron 2007, 63, 6146-6151.
8. (a) Belitsky, J. M.; Leslie, S. J.; Arora, P. S.; Beerman, T. A.; Dervan, P. B. Bioorg. Med. Chem. 2002, 70, 3313-3318.
9. (b) Crowley, K. S.; Phillion, D. P.; Woodard, S. S.; Scheitzer, B. A.; Singh, M.; Shabany, H.; Burnette, B.; Hippenmeyer, P.; Heitmeier, M.; Bashkin, J. K. Bioorg. Med. Chem. Lett. 2003, 73, 1565-1570.
10. (c) Best, T. P.; Edelson, B. S.; Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. USA. 2003, 700, 12063-12068.
11. (d) Edelson, B. S.; Best, T. P.; Olenyuk, B.; Nickols, N. G.; Doss, R. M.; Foister, S.; Heckel, A.; Dervan, P. B. Nucleic Acids Res. 2004, 32, 2802-2818.
12. (e) Xiao, X.; Yu, P.; Lim, H. S.; Sikder, D.; Kodadek, T. Angew. Chem., Int. Ed. 2007, 46, 2865-2868.
13. (f) Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. Nucleic Acids Res. 2007, 35, 363-370.
14. (g) Dose, C.; Farkas, M. E.; Chenoweth, D. M.; Dervan, P. B. J. Am. Chem. Soc. 2008, 730, 6859-6866.
15. (h) Hsu, C. F.; Dervan, P. B. Bioorg. Med. Chem. Lett. 2008, 78, 5851-5855.
16. (a) Gottesfeld, J. M.; Melander, C.; Suto, R. K.; Raviol, H.; Luger, K.; Dervan, P. B. J. Mol. Biol. 2001, 309, 615-629.
17. (b) Suto, R. K.; Edayathumangalam, R. S.; White, C. L.; Melander, C.; Gottesfeld, J. M.; Dervan, P. B.; Luger, K. J. Mol. Biol. 2003, 326, 371-380.
18. (c) Edayathumangalam, R. S.; Weyermann, P.; Gottesfeld, J. M.; Dervan, P. B.; Luger, K. Proc. Natl. Acad. Sci. U.S.A. 2004, 707, 6864-6869.
19. (d) Dudouet, B.; Burnett, R.; Dickinson, L. A.; Wood, M. R.; Melander, C.; Belitsky, J. M.; Edelson, B.; Wurtz, N.; Briehn, C.; Dervan, P. B.; Gottesfeld, J. M. Chem. Biol. 2003, 70, 859-867.
20. (a) Olenyuk, B. Z.; Zhang, G. J.; Klco, J. M.; Nickols, N. G.; Kaelin, Jr., W. G.; Dervan, P. B. Proc. Natl. Acad. Sci. USA. 2004, 101, 16768-16773.
21. (b) Kageyama, Y.; Sugiyama, H.; Ayame, H.; Iwai, A.; Fujii, Y.; Huang, L. E.; Kizaka-Kondoh, S.; Hiraoka, M.; Kihara, K. Acta Oncol. 2006, 45, 317-324.
22. (c) Nickols, N. G.; Jacobs, C. S.; Farkas, M. E.; Dervan, P. B. ACS Chem. Biol. 2007, 2, 561-571.
23. Nickols, N. G.; Dervan, P. B. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 10418-10423.
24. (a) Matsuda, H.; Fukuda, N.; Ueno, T.; Tahira, Y.; Ayame, H.; Zhang, W.; Bando, T.; Sugiyama, H.; Saito, S.; Matsumoto, K.; others, O. J. Am. Soc. Nephrol. 2006, 77, 422-432.
25. (b) Yao, E. H.; Fukuda, N.; Ueno, T.; Matsuda, H.; Matsumoto, K.; Nagase, H.; Matsumoto, Y.; Takasaka, A.; Serie, K.; Sugiyama, H.; Sawamura, T. Hypertension 2008, 52, 86-92.
26. (a) Baird, E. E.; Dervan, P. B. J. Am. Chem. Soc. 1996, 118, 6141-6146.
27. (b) Belitsky, J. M.; Nguyen, D. H.; Wurtz, N. R.; Dervan, P. B. Bioorg. Med. Chem. 2002, 70, 2767-2774.
28. (c) Wurtz, N. R.; Turner, J. M.; Baird, E. E.; Dervan, P. B. Org. Lett. 2001, 3, 1201-1203.
29. (d) Krutzik, P. O.; Chamberlin, A. R. Bioorg. Med. Chem. Lett. 2002, 72, 2129-2132.
30. (e) Krutzik, P. O.; Chamberlin, A. R. Methods Mol. Biol. 2002, 207, 77-92.
31. (f) Ayame, H.; Saito, T.; Bando, T.; Fukuda, N.; Sugiyama, H. Nucleic Acids Res. Suppl. 2003, 67-68.
32. (g) Moore, M. J. B.; Cuenca, F.; Searcey, M.; Neidle, S. Org. Biomol. Chem. 2006, 4, 3479-3488.
33. (a) Mrksich, M.; Parks, M. E.; Dervan, P. B. J. Am. Chem. Soc 1994, 776, 7983-7988.
34. (b) Xiao, J.; Yuan, G.; Huang, W.; Chan, A. S.; Lee, K. L. J. Org. Chem. 2000, 65, 5506-5513.
35. (c) Harris, D.; Stewart, M.; Sielaff, A.; Mulder, K.; Brown, T.; Mackay, H.; Lee, M. Heterocycl. Commun. 2007, 73, 17-23.
36. (d) Xiao, J.-H.; Huang, W.-Q.; Tang, F.-L.; Yuan, G.; Chan, A. S. C.; Lee, K-L. D. Chin. J. Chem. 2000, 78, 603-607.
37. (e) Boger, D. L.; Fink, B. E.; Hedrick, M. P. J. Am. Chem. Soc 2000, 122, 6382-6394.
38. (f) Mamidyala, S. K.; Firestine, S. M. Tetrahedron Lett. 2006, 47, 7431-7434.
39. Sources for commercially available building blocks 7-10 shown in Figure 2: 7, Fluorochem, cat. no. 019570; 8, Fluka, cat. no. 17974; 9, Bachern, cat. no. F-3480; 10, Bachem, cat. no. F-3485.
40. Jaramillo, D.; Liu, Q.; Aldrich-Wright, J.; Tor, Y. J. Org. Chem. 2004, 69, 8151-8153.
41. Dervan, P. B.; Sluka, J. P. Design of sequence-specific DNA binding molecules: bis(distamycin)phenoxazone. In New Synthetic Methodology and Functionally Interesting Compounds; Yoshida, Z., Ed.; Studies in Organic Chemistry 25; Elsevier: Amsterdam, 1986; pp 307-322.
42. Adlington, R. M.; Baldwin, J. E.; Becker, G. W.; Chen, B.; Cheng, L.; Cooper, S. L.; Hermann, R. B.; Howe, T. J.; McCoull, W.; McNulty, A. M.; Neubauer, B. L.; Pritchard, G. J. J. Med. Chem. 2001, 44, 1491-1508.